Literature DB >> 33759032

Cognitive Enhancement: Unanswered Questions About Human Psychology and Social Behavior.

Eric Racine1,2,3, Sebastian Sattler4,5, Wren Boehlen6.   

Abstract

Stimulant drugs, transcranial magnetic stimulation, brain-computer interfaces, and even genetic modifications are all discussed as forms of potential cognitive enhancement. Cognitive enhancement can be conceived as a benefit-seeking strategy used by healthy individuals to enhance cognitive abilities such as learning, memory, attention, or vigilance. This phenomenon is hotly debated in the public, professional, and scientific literature. Many of the statements favoring cognitive enhancement (e.g., related to greater productivity and autonomy) or opposing it (e.g., related to health-risks and social expectations) rely on claims about human welfare and human flourishing. But with real-world evidence from the social and psychological sciences often missing to support (or invalidate) these claims, the debate about cognitive enhancement is stalled. In this paper, we describe a set of crucial debated questions about psychological and social aspects of cognitive enhancement (e.g., intrinsic motivation, well-being) and explain why they are of fundamental importance to address in the cognitive enhancement debate and in future research. We propose studies targeting social and psychological outcomes associated with cognitive enhancers (e.g., stigmatization, burnout, mental well-being, work motivation). We also voice a call for scientific evidence, inclusive of but not limited to biological health outcomes, to thoroughly assess the impact of enhancement. This evidence is needed to engage in empirically informed policymaking, as well as to promote the mental and physical health of users and non-users of enhancement.

Entities:  

Keywords:  Enhancement; Ethics; Health; Human flourishing; Social psychology.; Well-being

Year:  2021        PMID: 33759032      PMCID: PMC7987623          DOI: 10.1007/s11948-021-00294-w

Source DB:  PubMed          Journal:  Sci Eng Ethics        ISSN: 1353-3452            Impact factor:   3.525


  67 in total

1.  Ageless bodies, happy souls: biotechnology and the pursuit of perfection.

Authors:  Leon R Kass
Journal:  New Atlantis       Date:  2003

2.  Effect of modafinil on learning and task-related brain activity in methamphetamine-dependent and healthy individuals.

Authors:  Dara G Ghahremani; Golnaz Tabibnia; John Monterosso; Gerhard Hellemann; Russell A Poldrack; Edythe D London
Journal:  Neuropsychopharmacology       Date:  2011-02-02       Impact factor: 7.853

3.  Benefit and risk of modafinil in idiopathic hypersomnia vs. narcolepsy with cataplexy.

Authors:  Sophie Lavault; Yves Dauvilliers; Xavier Drouot; Smaranda Leu-Semenescu; Jean-Louis Golmard; Michel Lecendreux; Patricia Franco; Isabelle Arnulf
Journal:  Sleep Med       Date:  2011-05-14       Impact factor: 3.492

Review 4.  Brain-computer interfaces and personhood: interdisciplinary deliberations on neural technology.

Authors:  Matthew Sample; Marjorie Aunos; Stefanie Blain-Moraes; Christoph Bublitz; Jennifer A Chandler; Tiago H Falk; Orsolya Friedrich; Deanna Groetzinger; Ralf J Jox; Johannes Koegel; Dennis McFarland; Valerie Neufield; David Rodriguez-Arias; Sebastian Sattler; Fernando Vidal; Gregor Wolbring; Andreas Wolkenstein; Eric Racine
Journal:  J Neural Eng       Date:  2019-11-11       Impact factor: 5.379

Review 5.  Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review.

Authors:  R M Battleday; A-K Brem
Journal:  Eur Neuropsychopharmacol       Date:  2015-08-20       Impact factor: 4.600

Review 6.  Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications.

Authors:  William D Graf; Saskia K Nagel; Leon G Epstein; Geoffrey Miller; Ruth Nass; Dan Larriviere
Journal:  Neurology       Date:  2013-03-13       Impact factor: 9.910

7.  Evaluating the drivers of and obstacles to the willingness to use cognitive enhancement drugs: the influence of drug characteristics, social environment, and personal characteristics.

Authors:  Sebastian Sattler; Guido Mehlkop; Peter Graeff; Carsten Sauer
Journal:  Subst Abuse Treat Prev Policy       Date:  2014-02-01

8.  Attitudes towards prescribing cognitive enhancers among primary care physicians in Germany.

Authors:  Andreas G Franke; Carolin Papenburg; Elena Schotten; Peter B Reiner; Klaus Lieb
Journal:  BMC Fam Pract       Date:  2014-01-08       Impact factor: 2.497

Review 9.  Attitudes toward pharmacological cognitive enhancement-a review.

Authors:  Kimberly J Schelle; Nadira Faulmüller; Lucius Caviola; Miles Hewstone
Journal:  Front Syst Neurosci       Date:  2014-04-17

Review 10.  Hacking the Brain: Dimensions of Cognitive Enhancement.

Authors:  Martin Dresler; Anders Sandberg; Christoph Bublitz; Kathrin Ohla; Carlos Trenado; Aleksandra Mroczko-Wąsowicz; Simone Kühn; Dimitris Repantis
Journal:  ACS Chem Neurosci       Date:  2019-01-02       Impact factor: 4.418

View more
  3 in total

1.  Neuroenhancements in the Military: A Mixed-Method Pilot Study on Attitudes of Staff Officers to Ethics and Rules.

Authors:  Sebastian Sattler; Edward Jacobs; Ilina Singh; David Whetham; Imre Bárd; Jonathan Moreno; Gian Galeazzi; Agnes Allansdottir
Journal:  Neuroethics       Date:  2022-02-28       Impact factor: 1.427

2.  Parents' Perceptions on the Debated Parenting Practice of Cognitive Enhancement in Healthy Children and Adolescents.

Authors:  Kati Hiltrop; Sebastian Sattler
Journal:  J Cogn Enhanc       Date:  2022-06-15

3.  Effort-Reward Imbalance at Work and Prescription Drug Misuse-Prospective Evidence from Germany.

Authors:  Sebastian Sattler; Olaf von dem Knesebeck
Journal:  Int J Environ Res Public Health       Date:  2022-06-22       Impact factor: 4.614

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.